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Introduction {#S0001}
============

*Chlamydia trachomatis (C. trachomatis)* is an obligate intracellular human pathogen which is responsible for the most reported bacterial sexually transmitted disease worldwide. Genital chlamydial infection has been identified as a major public health and there is an estimated annual incidence of around 92 million cases of chlamydial infections in the world ([@CIT0001]). Although, infection with this organism can be asymptomatic in up to 80% of women ([@CIT0002]), it may give rise to urethral syndrome, salpingitis, pelvic inflammatory disease (PID), tubal factor infertility and chronic pel vic pain ([@CIT0003]).

Infection of the female reproductive tract with *C. trachomatis* is one of the leading global causes of tubal factor infertility ([@CIT0004]), and leading causes of female factor infertility.

In order to reduce the rate of PID and prevent development of reproductive sequelae, early diagnosis and treatment of Chlamydial infection can be of great importance ([@CIT0005]). Since the prevalence of chlamydial diseases is on the rise, development of sensitive, specific, and rapid methods to diagnose this infections is highly favored.

Cell culture, cytological tests for the detection of cytoplasmic inclusion bodies, direct immunofluorescence (DFA), enzyme-linked immunosorbent assay (ELISA), DNA hybridization techniques and polymerase chain reaction (PCR) are several laboratory methods which are used for the diagnosis of *C. trachomatis* ([@CIT0006]).

Studies indicate that PCR has a sensitivity of 97% to 100% and a specificity of 98% for detecting *C. trachomatis*. The sensitivity and specificity of cell culture are 85% and 100%, respectively ([@CIT0007], [@CIT0008]). Therefore, cell culture is the gold standard for the diagnosis of *C. trachomatis*.

In this study, we used a nucleic acid amplification method (PCR) to detect and evaluate the prevalence of *C. trachomatis* infection in woman with tubal infertility using cytobrush and cervical swab samples.

Methods {#S0002}
=======

Patients and samples
--------------------

We recruited 51 women with tubal factor infertility, confirmed by laparos-copy and hysterosalpingography, attending Avicenna Infertility clinic in Tehran, Iran between January 2010 and January 2011. Patients were 19--48 years old (mean 33.3±SD years) and their age at first intercourse was 23.5±7.2 ranging from (10--43 years).

Cytobrush and cervical swab samples were obtained from each participant by the gynecologists. Swab and cytobrush samples were placed in PBS and 2sp (sucrose-phosphate) transport media, respectively, and were sent to laboratory under suitable protective (4°*C*) condition. The demographic data and medical histories were collected by direct interviews with the patients.

DNA extraction and PCR
----------------------

DNA was extracted from cervical swabs using DNA extraction kit (QIAGEN, Germany) according to the manufacturer\'s instructions. All the extracted DNA was stored at −20*°C* until analyzing by PCR. Primers for amplification of orf8 gene were:

Forward 5'-CTAGGCGTTTGTACTCCGTCA-3' and reverse 5'-TCCTCAGGAGTTTATGCACT-3'. After setting up, PCR was performed. The amplification program consisted of a first cycle of a 5 *min* denaturation at 94*°C*, followed by 37 cycles, each lasting 40 *s* at 94*°C*, 45 *s* at 61.6*°C*, and 89 *s*, at 72*°C*, with a final extension for 5 *min* at 72*°C*.

The volume of each PCR tube was 50 *µl* containing 5 *µl* DNA, 25 *mmol* MgCl2, 25 *mmol* dN TP, 1 *mmol* forward and reverse primers and 1.5 unit Taq polymerase. The amplified PCR product (5 *µl*) was analysed by electrophoresis on 1.5% *w/v* agarose gel containing 0.5 *µg/ml* of ethidium bromide.

Culture on McCoy cell line
--------------------------

Cytobrush samples were used for isolation of *C. trachomatis* in cycloheximide treated McCoy cell monolayer, which was grown on cover slip cultures in 12--well plates using RPMI supplement with 10% fetal bovine serum (FBS), 2 *mM* L-glutamine and antibiotics. Plates were incubated at 37*°C* for 2--3 days till adequate growth of bacteria appeared.

After vigorous vortexing, 200 *µl* of each cytobrush specimen was inoculated on the cells. The plates were centrifuged for 1 *hr* (1500 *g*, 30*°C*) and after replacement of medium, they were incubated at 37*°C* for 48--72 *hr* the monolyers were fixed in methanol and inclusion bodies were detected by Giemsa staining.

Data analysis
-------------

The data were analyzed by SPSS version 16 software. Chi square (*χ^2^*), Fisher\'s exact test, and independent t-test, were used for significance analysis. A p-value smaller than 0.05 was regarded as statistically significant.

Results {#S0003}
=======

Fifty-one infertile women who had failed to have children after one year of intercourse without contraception were enrolled in this study. Most of the participants belonged to the 30--35 year-old age group. About 67.4% of the aptients had a history of vaginal infection; 86.0% had primary infertility, and 64.7% were infertile for more that five years.

We amplified a fragment with a length of 200 *bp* during PCR and visualized it on 1.5% agarose gel ([Figure 1](#F0001){ref-type="fig"}). Cell cultures were performed in Mac Coy cell line ([Figure 2](#F0002){ref-type="fig"}).

![Detection of *C. trachomatis* from cervical swab specimens by PCR using orf8 primers. Lane 1, DNA size markers; Lane 2-5, positive patients for *C. trachomatis*; Lane 6, positive control; Lane 7, negative control](JRI-14-29-g001){#F0001}

![MacCoy cell line; A: before inoculation of specimen; B: after inoculation and C: after Gimsa staining](JRI-14-29-g002){#F0002}

According to the result presented in [Table 1](#T0001){ref-type="table"}, of 51 samples, 6 (11.7%) were positive by PCR and 2 (3.9%) by cell culture ([Table 1](#T0001){ref-type="table"}).

###### 

PCR and cell culture results in TFI patients

              Cell culture   Total                     
  ----------- -------------- ------------ ------------ -----------
  **PCR**     ^+^            2 (3.9%)     4 (7.8%)     6 (11.7%)
  \-          0 (0.0%)       45 (88.2%)   45 (88.2%)   
                                                       
  **Total**                  2 (3.9%)     49 (96%)     51 (100%)

The mean age at first intercourse was 30.67±9.89 and 22.72±6.45 in positive and negative PCRs, respectively, (p \< 0.05). Moreover, a significant relation was seen between the age at first intercourse and the risk of infection (p \< 0.05). About 18.8% of patients with an infertility duration less than 5 years versus 9.1% of those with an infertility duration more than 5 years had positive PCR results (p \< 0.05), while such a relation was not observed for cell culture.

T-test showed no significant relationship between the patients' age and *C. trachomatis* infection, but the possibility of infection increased significantly with increased age of marriage (p \< 0.05).

Infertility duration had a certain correlation with PCR results but it was not significant (p = 0.056) and showed no relationship with results obtained from cell culture.

Chi-squarea and Fisher\'s exact test were used to evaluate the relationship between symptoms of genital infections with PCR and culture results. None of the symptoms such as genital discharge, dysuria, genital itching or pelvic showed any significant association with the infection ([Table 2](#T0002){ref-type="table"}).

###### 

Frequency of symptoms in women with tubal factor infertility

  Symptoms              n     (*%*)
  --------------------- ----- -------
  **Genital**           36    70.58
  **Discharge**         18    35.29
  **Genital itching**   22    43.13
  **Genital**           12    23.52
  **Irritation**        18    35.29
  **Dysuria**           \--   \--
  **Pelvic pain**       \--   \--

Discussion {#S0004}
==========

Genital chlamydial infection, caused by the sexually transmitted bacterium *C. trachomatis*, is currently the most prevalent sexually transmitted infection throughout the world ([@CIT0001]). This infection has been associated with a wide spectrum of complications.

*C. trachomatis* is among the most common microorganisms interfering with female fertility and is considered the most important cause of tubal obstruction and PID ([@CIT0009]).

Therefore, screening and treatment of chlamydial infection in order to reduce its transmission and prevent PID and its long-term sequelae including infertility, chronic pain, PID and ectopic pregnancy are of great value.

About 10% to 20% of female infertility is associated with tubal factor infertility. Although *C. trachomatis* infection will effectively clear in most women, but infection persists in some and may ascend to the upper genital tract and increase the risk of tubal factor subfertility ([@CIT0010]). In the current study, we evaluated women with tubal factor infertility for *C. trachomatis* infection by PCR and cell culture.

Based on several investigations, prevalence of *C. trachomatis* infection varies with the population under study and the type and sensitivity of the detection methods used. For example, the prevalence of chlamydial DNA in fresh tissue specimens from 14 women with tubal factor infertility was investigated in UK. *C. trachomatis* DNA was detected in 43% of these patients ([@CIT0011]). The prevalence was 12% in our study, which is comparable with the results of other studies carried out in Iran, suggesting the lower incidence of this infection in our community.

Assessment of *C. trachomatis* infection in Iranian women with Cervicitis was done earlier by direct fluorescent antibody (DFA) and PCR techniques. About 15.5% of 142 samples were positive for *Chlamydia* based on PCR results, while DFA results showed a 14.1% positivity ([@CIT0012]). These data are comparable with PCR results of the current study, although the values had been higher for cell culture. This shows that PCR and DFA methods are more sensitive than cell culture.

Of 110 Indian women with primary and secondary infertilities, *C. trachomatis* was detected in 25 (22.72%) cases by cell culture method ([@CIT0013]), while we detected the organisms this way in only 4% of the cases. This difference could be due to different sample sizes and populations and perhaps better cell-culture techniques used in their study.

Endocervical swabs from 109 women attending gynecology and infertility clinics in Gaza were analyzed using PCR and enzyme immunoassay techniques. The results showed that overall prevalence rate of *C. trachomatis* to be 20.2% ([@CIT0014]).

In another study, the rate of *C. trachomatis* infection evaluated by PCR was 27.2% and 18.9% in asymptomatic and symptomatic women, respectively ([@CIT0015]).

Conclusion {#S0005}
==========

In the present study we used PCR and cell culture techniques to detect *C. trachomatis* in cervical swabs and cytobrush specimens. Based on PCR results, the prevalence of *C. trachomatis* in the study population was 12%, while cell culture detected the organism in only 4% of the cases.

In agreement with several other studies, our results showed that PCR is more sensitive than cell culture in detecting chlamydial infections.

Although culture was earlier considered the gold standard, its sensitivity is as low as 75% to 85% even in expert laboratories and it takes 3 to 6 days to complete ([@CIT0016]). But nucleic acid amplification methods, such as PCR, have high sensitivity and specificity and the results could be obtained within a short time. Furthermore in this method specimens will be stable during transport and can be subjected to delays between collection and processing without significant loss of sensitivity ([@CIT0017]).

Since undetected and untreated chlamydial infections may lead to many reproductive sequelae, such as infertility, the results of the current study suggest that all infertile women should referred to infertility clinics and be screened for *C. trachomatis* in our community.
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